These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8302755)

  • 1. A correlation between the permeability characteristics of a series of peptides using an in vitro cell culture model (Caco-2) and those using an in situ perfused rat ileum model of the intestinal mucosa.
    Kim DC; Burton PS; Borchardt RT
    Pharm Res; 1993 Dec; 10(12):1710-4. PubMed ID: 8302755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrogen bonding potential as a determinant of the in vitro and in situ blood-brain barrier permeability of peptides.
    Chikhale EG; Ng KY; Burton PS; Borchardt RT
    Pharm Res; 1994 Mar; 11(3):412-9. PubMed ID: 8008709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of structural modifications on the intestinal permeability of angiotensin II receptor antagonists and the correlation of in vitro, in situ, and in vivo absorption.
    Ribadeneira MD; Aungst BJ; Eyermann CJ; Huang SM
    Pharm Res; 1996 Feb; 13(2):227-33. PubMed ID: 8932441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic examination of the in vitro Ussing chamber and the in situ single-pass perfusion model systems in rat ileum permeation of model solutes.
    Tsutsumi K; Li SK; Ghanem AH; Ho NF; Higuchi WI
    J Pharm Sci; 2003 Feb; 92(2):344-59. PubMed ID: 12532384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of in vitro and in vivo models for the oral absorption of peptide drugs.
    Föger F; Kopf A; Loretz B; Albrecht K; Bernkop-Schnürch A
    Amino Acids; 2008 Jun; 35(1):233-41. PubMed ID: 17726639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of peptide structure on transport across Caco-2 cells.
    Conradi RA; Hilgers AR; Ho NF; Burton PS
    Pharm Res; 1991 Dec; 8(12):1453-60. PubMed ID: 1808606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective paracellular permeability in two models of intestinal absorption: cultured monolayers of human intestinal epithelial cells and rat intestinal segments.
    Artursson P; Ungell AL; Löfroth JE
    Pharm Res; 1993 Aug; 10(8):1123-9. PubMed ID: 8415396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of peptide structure on transport across Caco-2 cells. II. Peptide bond modification which results in improved permeability.
    Conradi RA; Hilgers AR; Ho NF; Burton PS
    Pharm Res; 1992 Mar; 9(3):435-9. PubMed ID: 1614980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional Intestinal Permeability in Rats: A Comparison of Methods.
    Roos C; Dahlgren D; Sjögren E; Tannergren C; Abrahamsson B; Lennernäs H
    Mol Pharm; 2017 Dec; 14(12):4252-4261. PubMed ID: 28920690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAMPA--a drug absorption in vitro model 7. Comparing rat in situ, Caco-2, and PAMPA permeability of fluoroquinolones.
    Bermejo M; Avdeef A; Ruiz A; Nalda R; Ruell JA; Tsinman O; González I; Fernández C; Sánchez G; Garrigues TM; Merino V
    Eur J Pharm Sci; 2004 Mar; 21(4):429-41. PubMed ID: 14998573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of the intestinal absorption of an ester-type prodrug, ME3229, in rats: active efflux transport as a cause of poor bioavailability of the active drug.
    Okudaira N; Tatebayashi T; Speirs GC; Komiya I; Sugiyama Y
    J Pharmacol Exp Ther; 2000 Aug; 294(2):580-7. PubMed ID: 10900235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of drug absorption with molecular surface properties.
    Palm K; Luthman K; Ungell AL; Strandlund G; Artursson P
    J Pharm Sci; 1996 Jan; 85(1):32-9. PubMed ID: 8926580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption and intestinal metabolism of purine dideoxynucleosides and an adenosine deaminase-activated prodrug of 2',3'-dideoxyinosine in the mesenteric vein cannulated rat ileum.
    Singhal D; Ho NF; Anderson BD
    J Pharm Sci; 1998 May; 87(5):569-77. PubMed ID: 9572907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing Oral Bioavailability of Cyclic RGD Hexa-peptides by the Lipophilic Prodrug Charge Masking Approach: Redirection of Peptide Intestinal Permeability from a Paracellular to Transcellular Pathway.
    Schumacher-Klinger A; Fanous J; Merzbach S; Weinmüller M; Reichart F; Räder AFB; Gitlin-Domagalska A; Gilon C; Kessler H; Hoffman A
    Mol Pharm; 2018 Aug; 15(8):3468-3477. PubMed ID: 29976060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical determinants of passive membrane permeability: role of solute hydrogen-bonding potential and volume.
    Goodwin JT; Conradi RA; Ho NF; Burton PS
    J Med Chem; 2001 Oct; 44(22):3721-9. PubMed ID: 11606137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of simulated intestinal fluids with Caco-2 cells and rat ileum.
    Patel N; Forbes B; Eskola S; Murray J
    Drug Dev Ind Pharm; 2006 Feb; 32(2):151-61. PubMed ID: 16537196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic modelling of the intestinal transport of sarafloxacin. Studies in situ in rat and in vitro in Caco-2 cells.
    Fernandez-Teruel C; Gonzalez-Alvarez I; Casabó VG; Ruiz-Garcia A; Bermejo M
    J Drug Target; 2005 Apr; 13(3):199-212. PubMed ID: 16036308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved prediction of in vivo peroral absorption from in vitro intestinal permeability using an internal standard to control for intra- and inter-rat variability.
    Dowty ME; Dietsch CR
    Pharm Res; 1997 Dec; 14(12):1792-7. PubMed ID: 9453070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between structure and permeability of tryptophan derivatives across human intestinal epithelial (Caco-2) cells.
    Urakami M; Ano R; Kimura Y; Shima M; Matsuno R; Ueno T; Akamatsu M
    Z Naturforsch C J Biosci; 2003; 58(1-2):135-42. PubMed ID: 12622240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system.
    Nerurkar MM; Burton PS; Borchardt RT
    Pharm Res; 1996 Apr; 13(4):528-34. PubMed ID: 8710741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.